Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel

Anti-Cancer Drugs

Volumn 11, Issue 4, 2000, Pages 275-278

  Szlosarek, Piotr W ^a   Lofts, Fiona J ^a   Pettengell, Ruth ^a   Carter, Paul ^a   Young, Martin ^a   Harmer, Clive ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Carboplatin; Endometrial stromal sarcoma; Filgrastim; Paclitaxel; Peripheral blood progenitor cells

Indexed keywords

CARBOPLATIN; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; ENDOMETRIUM CANCER; FEMALE; FEMALE INFERTILITY; HUMAN; LUNG TUBERCULOSIS; PRIORITY JOURNAL; SARCOMA; STEM CELL TRANSPLANTATION; STROMA CELL; THROMBOCYTOPENIA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; ENDOMETRIAL NEOPLASMS; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; NEOPLASM STAGING; PACLITAXEL; SARCOMA, ENDOMETRIAL STROMAL; THROMBOCYTOPENIA; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION CONDITIONING; TUBERCULOSIS, PULMONARY;

EID: 0034086759     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200004000-00008     Document Type: Article

References (24)

1. 1. Zaloudek C, Norris HJ. Mesenchymal tumors of the uterus. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract. New York: Springer 1994: 501-9.
2. 2. De Fusco PA, Gaffey TA, Malkasian GD, Long HJ, Cha SS. Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945-1980. Gynecol Oncol 1989; 35: 8-14.
3. 3. Yoonessi M, Hart WR. Endometrial stromal sarcomas. Cancer 1977; 40: 898-906.
4. 4. Norris HJ, Taylor HB. Mesenchymal tumors of the uterus. A clinical and pathologic study of 53 endometrial stromal rumors. Cancer 1969; 19: 1413-22.
5. 5. Sarcoma Meta-Analysis Collaboration. Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 1997; 350: 1647-54.
6. 6. Demetri GD. Major developments in the understanding and treatment soft-tissue sarcomas in adults. Curr Opin Oncol 1998; 10: 343-47.
7. 7. Mansi JL, Ramachandra S, Wiltshaw E, Fisher C. Case report: endometrial stromal sarcomas. Gynecol Oncol 1990; 36: 113-8.
8. 8. Echt G, Jepson J, Steel J, et al. Treatment of uterine sarcomas. Cancer 1990; 66: 35-9.
9. 9. Sutton GP, Stehman FB, Michael H, Young PC, Ehrlich CE. Estrogen and progesterone receptors in uterine sarcomas. Obstet Gynecol 1986; 68: 709-14.
10. 10. Sutton G, Blessing JA, Park R, DiSaia PJ, Rosenshein N. Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. Obstet Gynecol 1996; 87: 747-50.
11. 11. Sutton G, Blessing JA, Malfetano JH. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 1996; 62: 226-9.
12. 12. Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL. Treatment of endometrial stromal tumors. Gynecol Oncol 1990; 36: 60-5.
13. 13. Omura GA, Major FJ, Blessing JA, Sediacek TV, Thigpen JT, Creasman WT. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 1983; 52: 626-32.
14. 14. Lehrner LM, Miles PA, Enck, R. Complete remission of widely metastatic endometrial stromal sarcoma following combination chemotherapy. Cancer 1979; 43: 1189-94.
15. 15. Yamawaki T, Shimizu Y, Hasumi K. Treatment of stage IV 'high-grade' endometrial stromal sarcoma with ifosfamide, adriamycin and cisplatin. Gynecol Oncol 1997; 64: 265-9.
16. 16. Kakimoto K, Ando Y. Successful treatment of recurrent endometrial stromal sarcoma by radiotherapy and intraarterial chmotherapy with CDDP and ADM. Jap J Cancer Chemother 1996; 3: 1209-12.
17. 17. Du Bois A, Richter B, Warm M, et al. Cisplatin/paclitaxel vs carboplatin/paclitaxel as 1st-line treatment in ovarian cancer. Proc Am Soc Clin Oncol 1998; 17: 1395.
18. 18. Goldstein D, Cheuvert B, Trump DL, et al. Phase II trial of carboplatin in soft-tissue sarcoma. Am J Clin Oncol 1990; 13: 420-3.
19. 19. Takada S, Tamura A, Hiraoka K, Ogino M, Mori H, Imamura T. A case of remission of recurrent carcinosarcoma of the uterus with massive ascites by carboplatin. Jap J Cancer Chemother 1995; 22: 1253-6.
20. 20. Kudelka AP, Termrungruanglert W, Vadhan-Raj S, et al. Remission of advanced uterine leiomyosarcoma with pulmonary metastases with carboplatin and paclitaxel. Anti-Cancer Drugs 1996; 7: 885-9.
21. 21. Balcerzak SP, Benedetti J, Weiss GR, Natale RB. A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. Cancer 1995; 76: 2248-52.
22. 22. Pettengell R, Woll PJ, Thatcher N, Dexter TM, Testa NG. Multicyclic, dose-intensive chemotherapy, supported by sequential reinfusion of haematopoietic progenitors in whole blood. J Clin Oncol 1995; 13: 148-56.
23. 23. Calvert AH, Newell DR, Gunbrell LA, et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989; 7: 1748-56.
24. 24. Savarese DMF, Chung-cheng H, Stewart FM. Clinical impact of chemotherapy dose escalation in patients with haematologic malignancies and solid tumors. J Clin Oncol 1997; 15: 2981-95.